Patent information
IP India · live recordAbstract
The present invention relates to a bio-printing system for real-time vivo wound healing comprising a scanning unit (5), a user interface (4), a controlling unit (2) and a bio-printing device (1) comprising an end-effector (6) contiguous to a manipulator arm for depositing bio-ink on a target area, further comprising a primary mounting (14) allowing sliding of atleast two hollow elongated secondary mountings (15a, 15b) via a rack and pinion arrangement, a scanner for real-time monitoring of target area, atleast two bio-mixture filled replaceable syringes (17a, 17b) insertable inside the secondary mountings (15a, 15b) to dispense bio-inks onto target region depending on the strength of actuation received via an inbuilt linear actuator (21) and atleast one ultra-violet lamp (18) to disinfect and solidify upper layer of the bio-ink dispensed on the target area.
Applicants
4Inventors
9Specification
Show full textCollapse
The present invention relates to the field of 3D printing/additive manufacturing. More particularly present invention relates to 3D bio-printers. Even more particularly, present invention relates to a 3D bio-printer and system for real-time in vivo wound healing by flexibly injecting bio-inks onto the wounds 10 and covering them with a biodegradable layer. BACKGROUND OF THE INVENTION
[0002] Background description includes information that may be useful in 15 understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] Charles Hull was the first one to develop bio-printing in 1983 by inventing 20 stereo-lithography that gradually led to the development of 3D bio-printing organs. Bio-printing is a type of 3D printing/additive manufacturing that aims at precisely dispensing out cell-laden biomaterials, thereby forming complex and functional living tissues and/or artificial organs. The process of 3D bio-printing includes a first step of performing CAD modeling of the received images of living 25 tissues/artificial organs, printing the modeled CAD images via bio-inks filled in a bio-printer and then lastly, post-processing the printed living tissues/artificial organs as per the further requirements.
[0004] The following years have seen advancements in different types of bio30 printing technologies, most of them aiming significantly towards development of scaffolds-fee bio-printing technologies and others aiming at improving the cell- 4 viability. So far, a combination of different biomaterials, cells, human-friendly chemicals, and multiple physiological and physiochemical factors have been incorporated to ensure recovery of diseases/injuries and tissue development. 5 [0005] US6,408,224B1 discloses a rotary articulated robot having atleast multiple offset rotary joints having a drive arm and a driven arm respectively in rotation about an offset rotary axis having inclination with respect to the arm axis, a hollow rotary shaft arranged rotatably and driven in rotation by a motor such that such hollow rotary shaft and a rotor member constitute a high reduction ratio 10 transmission/torque increasing mechanism. As per a method of control thereof, the operation of joints is analyzed by dividing the end effector into multiple blocks such that the operating conditions for each joint necessary for movement to prescribed block are converted to database form for each block, a database form is generated for the teaching of operating points in the prescribed block region. 15 Finally, on the basis of block region data, a track is generated to the block of operating region such that the in-block operating point is fetched when a reference point of block is reached.
[0006] WO2017011854A1 discloses a method of 3D tissue culture modeling 20 comprising steps of printing a drop of bio-ink onto a substrate, printing a drop of activator to the drop of bio-ink, thereby forming a hydrogel droplet, repeating the aforementioned two steps in any order to form a hydrogel mold adapted to receive drop containing cells, printing such drop containing cells on a hydrogel mold and then repeating again the first two steps to form a 3D tissue culture model that 25 comprises of the cells encapsulated within the hydrogel mold.
[0007] Though several works have been tried to perform tissue generation and live organ development to enhance tissue engineering, the major challenge faced by all such works is their incapability to be performed in real-time for live in vivo 30 wound healing. 5
[0008] Most of the researches has been done to make portable 3D bio-printed organs, both with and without scaffolds, but the application of same technologies for real-time tissue generation on human subjects has not yet been proven tangible and fruitful. Many companies have launched products intended for printing organs 5 and small vessel trees, but unfortunately, these products cannot be tested directly on human body because of their inflexibility.
[0009] People have gathered huge funds and monetary supports in this field and have pioneered some of the main bio-printing techniques that are known today, 10 but it has been observed according to the facts that these techniques are often too expensive, slow and sensitive and are hence conducted with maximum possible care and measures.
[0010] Some of the bio-printing processes like the Laser-Induced Forward 15 Transfer (LIFT) and Trix Assisted Pulsed Laser Evaporation Direct Writing (TAPLEDW) often lead to poor control of single cells but have higher throughput and resolution. The heat generated often damages and hinders the viability of the cells taken into the account. 20 [0011] The key problem faced by the aforementioned bio-printing technologies is cell sources thereof, as cells are not found in abundance and take time to culture. Notably, stem cells are seen to be of high viability but short life cycle and due to their functional transferability, these may reduce the number and types of cells utilized while bio-printing. 25
[0012] Printing living tissues and organs clearly requires a 3D approach. There is manual assembling of 2D cell sheets done into 3D tissue-like structures, but there are some limitations faced by the researchers in terms of automation, scalability, and low speed that eventually leads to long printing hours. The concept of organ 30 printing which is based on the principles of directed step by step and/or layer by 6 layer deposition and sequential biological tissue self-assembly is one of the main challenges faced by researchers these days.
[0013] Introduction of robotics and artificial intelligence in the field of bio5 printing can enable researchers to touch and interact with various aspects of tissue engineering. The challenge is to make an anthropomorphic, flexible, agile, and robust 3D bio-printing device and a system that can store different types of cell mixture for a longer time and can heal the wounds and cuts in any condition and pattern with the embedded artificial intelligence. 10 OBJECTS OF THE INVENTION
[0014] The principal object of the present invention is to overcome the disadvantages of the prior art. 15
[0015] An object of the present invention is to provide an anthropomorphic, portable, flexible, agile, and robust 3D bio-printing device.
[0016] Another object of the present invention is to facilitate real-time wound 20 healing of living organisms, especially human subjects.
[0017] Another object of the present invention is to facilitate live monitoring of the bio-printing process via proper scanning and record keeping of target area. 25 [0018] Yet another object of the present invention is to provide a remotely/wirelessly accessible bio-printing device.
[0019] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following 30 detailed description of the preferred embodiment as illustrated in the 7 accompanying drawings. SUMMARY OF THE INVENTION 5 [0020] The present invention relates to a flexible, agile, and robust 3D bioprinting device for real-time wound healing by injecting regenerative bio-inks and a system for live monitoring thereof.
[0021] According to an embodiment of the present invention, a bio-printing 10 system for real-time in vivo wound healing is disclosed, comprising at least one scanning unit for acquiring one or more three-dimensional images of at least one injured area, a user interface linked to the at least one scanning unit for generating computer-aided designs based on features extracted via machine learning regression modeling of the images, at least one bio-printing device operable to 15 patternly deposit bio-inks onto the injured area based on the designs and a controlling unit facilitating the patternly deposition by transferring plurality of instructions between the user interface and the bio-printing device.
[0022] According to another embodiment of present invention, the system further 20 comprises a temperature controlling unit to maintain cell viability and temperature propitious for bio-ink deposition. Also, the scanning unit further comprises of at least one position sensor for spotting the injured area, thereby assisting the scanning unit to align thereto. 25 [0023] According to another embodiment of present invention, a bio-printing device for real-time in vivo wound healing is disclosed comprising a flexible manipulator arm and an end-effector contiguous to the arm for depositing bio-ink on a target area, further comprising a primary mounting, wherein elongated end of the primary mounting equips a pinion, atleast two hollow elongated secondary 30 mountings, wherein a side of the secondary mountings clamp a rack to lockably engage the pinion, thereby allowing sliding/switching of the secondary 8 mountings with respect to the primary mounting, a scanner connected to the primary mounting for real-time monitoring of the target area, atleast two biomixture filled replaceable syringes insertable inside the secondary mountings to dispense bio-inks onto the target region depending on the strength of actuation 5 received via an inbuilt linear actuator and atleast one ultra-violet lamp attached on atleast one secondary mounting to disinfect and solidify upper layer of the bioink dispensed on the target area.
[0024] According to another embodiment of present invention, the manipulator 10 arm further comprising a base affixed on a surface, a shoulder attached to the base via atleast one swivel joint, an upper arm attached to the shoulder via atleast a revolute joint, a lower arm attached to the upper arm via atleast another revolute joint and ending with the end-effector. 15 [0025] According to another embodiment of present invention, the manipulator is rotatable in six degrees of freedom and operational via plurality of servo motors. Moreover, the primary mounting further comprises of a motor actuated rotating shaft for driving the pinion. 20 [0026] According to another embodiment of present invention, the bio-mixture inside atleast two syringes consist of bio-material mixed with hydrogels of any cell type and/or a photosensitive ultra-violet curable bio-material respectively or a combination thereof. Also, the bio-material is selected to be but not limited to stem cells, mesenchymal cells, coalescent cells or combination thereof. The linear 25 actuator encompasses upper portion inside each of the secondary mountings and comprises a piston disposed there-below.
[0027] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be 30 possible that would fall within the scope of the present invention. 9 BRIEF DESCRIPTION OF THE DRAWINGS 5 [0028] The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure and, together with the description, serve to explain the principles of the present disclosure. 10
[0029] In the figures, similar components and/or features may have the same reference label. Further various components of the same type may be distinguished by following the reference label with a second label that distinguishes among the similar components. If only the first reference label is 15 used in the specification, the description is applicable to any of the similar components having the same reference label irrespective of the second reference label. Figure 1 illustrates a schematic representation of an exemplary bio-printing environment for a bio-printing device, according to an embodiment of present 20 invention; Figure 2 illustrates a block diagram of a bio-printing system, according to an embodiment of present invention. Figure 3 illustrates a top view of a three-dimensional bio-printing device operating on an exemplary test subject, showing the maximum reachability of the 25 device and a magnified view of process taking place onto the subject, according to an embodiment of present invention; Figure 4 depicts schematics on the workspace of the bio-printing device, thus demonstrates the reachability thereof, according to an embodiment of present invention; 30 Figure 5 illustrates front view of embodiments comprised within end effector of bio-printing device and a dual nozzle changing mechanism, according to an 10 embodiment of present invention; and Figure 6 presents a side view of end-effector of bio-printing device, according to an embodiment of present invention. Figure 7 illustrates a flow chart of sequential stages of process to accomplish 3D 5 printing, according to an embodiment of present invention. DETAILED DESCRIPTION OF THE INVENTION
[0030] As used in the description herein and throughout the claims that follow, 10 the meaning of “a,” “an,” and “the” includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of “in” includes “in” and “on” unless the context clearly dictates otherwise.
[0031] If the specification states a component or feature “may”, “can”, “could”, or 15 “might” be included or have a characteristic, that particular component or feature is not required to be included or have the characteristic.
[0032] Exemplary embodiments will now be described more fully hereinafter with reference to the accompanying drawings, in which exemplary embodiments 20 are shown. This disclosure may however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein. These embodiments are provided so that this disclosure will be thorough and complete and will fully convey the scope of the disclosure to those of ordinary skill in the art. Moreover, all statements herein reciting embodiments of the disclosure, as 25 well as specific examples thereof, are intended to encompass both structural and functional equivalents thereof. Additionally, it is intended that such equivalents include both currently known equivalents as well as equivalents developed in the future (i.e., any elements developed that perform the same function, regardless of structure). 30
[0033] Various terms as used herein are shown below. To the extent a term used 11 in a claim is not defined below, it should be given the broadest definition persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing. 5 [0034] In some embodiments, the numerical parameters set forth in the written description and attached claims are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding 10 techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The numerical values presented in some embodiments of the invention may contain certain errors necessarily resulting from the standard 15 deviation found in their respective testing measurements.
[0035] The present invention relates to a device and a system for real-time in vivo wound healing by flexibly injecting bio-inks onto the target area, thereby covering it with a solidified biodegradable layer of regenerative cells. 20
[0036] Referring to Figure 1 and 2, a schematic representation of an exemplary bio-printing environment for a bio-printing device, according to an embodiment of present invention is illustrated. The exemplary bio-printing environment comprises of the bio-printing device (1), a controlling unit (2), power supply (3) 25 as visible along with a user interface (4) and a scanning unit (5). One of the components of the bio-printing device (1), as disclosed in one of the embodiments, is a manipulator arm contiguous to an end-effector (6) for depositing bio-ink on a target area. The target area here refers to the cut/wound in vivo, especially a human subject but not limited thereto. If needed, the device (1) 30 can also be used to print live organs, blood vessels and many more from a Petri dish to big live animals or mammals. 12
[0037] The manipulator arm further comprises of a base (7) affixed on a surface, a shoulder (8) attached to the base (7) via atleast one swivel joint (9), an upper arm (10) attached to the shoulder (8) via atleast one revolute joint (11), a lower arm 5 (12) attached to the upper arm (10) via atleast another revolute joint (13) and ending with the end-effector (6). Herein, the surface may be made up of but not limited to metal, stone, wood and cement.
[0038] The swivel joints (9) and the revolute joints (11, 13) can be driven via 10 plurality of stepper/servo motors, thus making the manipulator arm flexibly rotatable in the three-dimensional space (having six degrees of freedom). Moreover, the joints are attached to the shoulder (8), upper arm (10) and lower arm (12) respectively with the help of nuts and bolts which causes proper fixation of servo/stepper motor. Additionally, an extra portion can be added to the 15 manipulator arm if there is any need to increase the work area of the bio-printing device (1). The end-effector (6) attached at the end of the manipulator arm is the main inventive step disclosed herein and operable to dispense bio-inks onto the target area. 20 [0039] Referring to Figure 2, a block diagram of a bio-printing system for realtime in vivo wound healing is illustrated according to an embodiment of present invention. The system comprises of atleast one scanning unit (5) for acquiring one or more three-dimensional images of the injured area. The scanning unit (5) aims to acquire the images from each and every angle to get a very thorough idea of the 25 injured region. According to an alternate embodiment, cameras can also be employed at different angles for getting more precise and close scanning and supervision.
[0040] A user interface (4) is used in order to generate computer-aided designs 30 (CAD) of the scanned images. The features of the acquired images can firstly be extracted by applying machine learning regression modeling (Artificial 13 Intelligence) on the acquired images. Machine learning regression modeling is a type of predictive modeling that investigates the differences between the injured area and actual area before injury to predict the structural pattern to be structured onto the injured area using bio-inks. 5
[0041] The controlling unit (2) has an in-built Human Machine Interface (HMI) that allows the user to interact therewith and also show about the proceedings of different processes in a structured manner. The CAD designs can be prepared automatically by the system predictive analysis or manually by a user. Further, the 10 bio-printing device (1) operates onto the target area to deposit bio-inks depending on the required predicted pattern, thereby healing the wound layer by layer.
[0042] Notably, plurality of instructions is required to reciprocate the predictive analysis done by the user interface practically onto the target area via the bio15 printing device (1). Such plurality of instructions can be provided through a controlling unit (2) which is responsible for continually transferring plurality of instructions between the user interface (4) and the bio-printing device (1). The controlling unit (2) can be referred to as the brain of the bio-printing system. 20 [0043] According to an embodiment, a temperature controlling unit can be employed to maintain cell viability as well as to maintain temperature propitious for the bio-ink deposition onto the injured area. Additionally, atleast one position sensor assists in spotting the injured area accurately and precisely, thereby assisting the scanning unit (5) to align thereon. Also, there can be robotic 25 calibration and positioning sensors and detectors to ascertain the relative height of the end-effectors (6) with respect to the target region it will come in contact with.
[0044] As indicated in figure 3, a top view of three-dimensional bio-printing device (1) operating on an exemplary test subject, showing the maximum 30 reachability of the device and a magnified view of process taking place onto the 14 subject is illustrated. Figure 3 depicts a human being laid on the operation table and bio-printing taking place on his/her body with proper synchronization a scanner for live monitoring of the process. A magnified view of the process taking place onto the skin with precision and accuracy is also presented. Herein, 5 positioning system is controlled by the manipulator and the scanning unit (5) that can scan whole body to find out the affected area.
[0045] In figure 4, schematics on the workspace of the bio-printing device (1) are depicted, thus demonstrates the reachability thereof, according to an embodiment 10 of present invention. Collective reachability of figure 3 and figure 4 provides a good amount of information about the flexibility that afore-discussed printing system and device inherit.
[0046] Referring to figure 5, front view of embodiments comprised within end 15 effector of bio-printing device (1) and a dual nozzle changing mechanism is illustrated, according to an embodiment of present invention. The end-effector (6) is contiguous to the flexible manipulator arm and performs the function of depositing bio-ink on the target area. Specifically, the end-effector is aligned at 45 degrees at the end of the lower arm (12). The end-effector (6) further comprises of 20 a primary mounting (14), atleast two hollow elongated secondary mountings (15a, 15b), a scanner, atleast two bio-mixture filled replaceable syringes (17a, 17b) and an ultra-violet lamp (18).
[0047] According to an embodiment of present invention, the primary mounting 25 (14) is T-shaped and made up of metal or aluminum. The mounting (14) is provided with an aim to impart strength and stability to embodiments attached thereto. The elongated end of the T-shaped primary mounting (14) terminates with a pinion (19). The pinion (19) herein is a part of a rack and pinion arrangement formed on the primary mounting (14) and the secondary mountings 30 (15a, 15b). The primary mounting (14) is highly flexible in nature having six degrees of freedom of motion. 15
[0048] The secondary mountings (15a, 15b) are two or more in count and hollow from inside to equip further embodiments. The secondary mountings (15a, 15b) are also made up of aluminum or metal such that a side, preferably inner side of 5 the secondary mountings (15a, 15b) clamp the rack (20) of the aforementioned rack and pinion arrangement, such that the rack (20) lockably engages on the pinion (19) to form the arrangement. As presented in the figure 5, such rack and pinion arrangement based connection between the primary mounting (14) and atleast two secondary mountings (15a, 15b) allows the sliding motion (up and 10 down motion) of the secondary mountings (15a, 15b) with respect to the primary mounting (14) and also assists in switching of the secondary mountings (15a, 15b) while depositing bio-inks on the target area, according to the requirement.
[0049] The scanner is affixed at the back of the primary mounting (14) to perform 15 blue light scanning of the target area to detect the exact location of interest. Moreover, the scanner also performs real-time monitoring of the target area whilst bio-ink is being dispensed thereon.
[0050] Each of the secondary mountings (15a, 15b) will consist of a linear 20 actuator (21) with actuator stroke of 50 mm up till 200 mm with gear ratio of 22:1. The linear actuator (21) encompasses upper portion inside each of said secondary mountings (15a, 15b) and comprises a piston (22) disposed therebelow. In the lower portion inside said secondary mountings (15a, 15b), biomixture filled syringe (17a, 17b) can be inserted whenever bio-printing needs to 25 take place. The syringe (17a, 17b) will be installed to prevent thereof from environmental factors, serve as covering and/or keep the bio-material preserved. The syringe (17a, 17b) will be in the form of use and throw syringes which will be bio-degradable and can be recycled hence, and environmental safety is taken into account. 30 16
[0051] The bio-mixture filled inside the barrel of the syringes (17a, 17b) consist of bio-material mixed with hydrogels/cellularized matrix/de-cellularized matrix of any cell type and/or a photosensitive ultra-violet curable bio-material respectively or a combination thereof. Moreover, the bio-material is selected to be but not 5 limited to stem cells, mesenchymal cells, coalescent cells or combination thereof. Particularly, in one of the syringes, (17a or 17b) there will be bio material (stem cells or a mesenchymal cell) mixed with the hydrogel and in the other syringe (17b or 17a) there will be a photosensitive bio-material that solidifies when made to interact with ultra-violet or a white light. 10
[0052] When the syringes (17a, 17b) are inserted into the secondary mountings (15a, 15b), the piston (22) of the linear actuator (21) attach to the plunger (23) of the syringes (17a, 17b) such that the push/pull based pressure exerted on the linear actuator (21), stimulates the plunger (23) of the syringes (17a, 17b) to be 15 pressed, leading to injection of bio-material from the needle of the syringes (17a, 17b). Biodegradable material gets deposited on the target region as a result of layer by layer stimulated injection of bio-material, thereby facilitating real-time healing of the wound. 20 [0053] According to an embodiment, one of the secondary mountings (15a, 15b) can be connected to an ultra-violet (UV) lamp (18), that is connected to the movable syringe (17a, 17b) slot with the help of nuts and bolts and which is working under the variable wavelength of 10 nm to 400 nm that can be set according to the needed circumstances. The UV lamp (18) serves as a disinfecting 25 device to make the environment infection and bacteria free and is also be used to solidify the uppermost layer of the print that actually consists of deposition of photo cross-linked polymer, thus leaving it unharmed and undisturbed. This method will create an envelope for the bio-print to cause the regenerative tendencies and increase curing time. Spacing can be provided between the target 30 areas and printing syringe so that printing process remains smooth and efficient. There will be sensor installed in the secondary mounting (15a, 15b) to give 17 information about the requirement of other syringes and when the material inside the syringe will be on the verge of finishing. Additionally, one or more sensors can be employed to detect non-geometric properties of material dispensed onto the target region. 5
[0054] The syringe’s needle (16) places the bio-material drop by drop onto the target area to implement layer by layer deposition. Once some layers are left, the syringe (17a) containing bio-material is turned up and the syringe (17b) containing photo-crosslinked bio-material or environment friendly polymer is 10 turned down at the distance where the previous syringe (17a) was. This syringe (17b) causes placement of the photo cross-linked bio-material onto the target area and simultaneously UV lamp (18) starts to solidify the upper most layer so as to prevent leaking thereof. The overall system and design improves the real-time in vivo healing capacity and regeneration of cells. 15
[0055] Figure 6 indicates a side view of end effector (6) of the bio-printing device (1). The figure clearly shows the positioning of a rotating shaft (25) for driving the pinion (19) of the rack and pinion arrangement that is actuated by a servo/stepper motor. The aforementioned rotating shaft can be mounted on the 20 back of the primary mounting (14). Specifically, the arrangement referred herein not only facilitates the sliding action of atleast two secondary mountings (15a, 15b) linearly up and down with respect to the primary mountings (14), but also assists in switching of the secondary mountings (15a, 15b) (and thus the syringes (17a, 17b)) according to the operation to the requirement/operation. 25
[0056] Figure 7 indicates a flow chart of sequential stages of process to accomplish 3D printing, according to an embodiment of present invention. The process comprises steps of detecting the injured area within its 3D reachable space and dimensioning of printing surface by scanning unit (5), 30 reconstructing/manual designing for the filing of wound in a manner that it takes shape of a skin using a third party software. Either automatic or manual CAD 18 modeling can be used for surface reconstruction, thereupon transferring the coded information to controlling unit (2), which inturn controls the end-effector (6) of the manipulator arm to work accordingly and thus ensure real-time healing of the cut/would layer by layer. 5
[0057] It should be apparent to those skilled in the art that many more modifications besides those already described are possible without departing from the inventive concepts herein. The inventive subject matter, therefore, is not to be restricted except in the spirit of the appended claims. Moreover, in interpreting 10 both the specification and the claims, all terms should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “includes” and “including” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with 15 other elements, components, or steps that are not expressly referenced. Where the specification claims refer to at least one of something selected from the group consisting of A, B, C ….and N, the text should be interpreted as requiring only one element from the group, not A plus N, or B plus N, etc. The foregoing description of the specific embodiments will so fully reveal the general nature of 20 the embodiments herein that others can, by applying current knowledge, readily modify and/or adapt for various applications such specific embodiments without departing from the generic concept, and, therefore, such adaptations and modifications should and are intended to be comprehended within the meaning and range of equivalents of the disclosed embodiments. It is to be understood that 25 the phraseology or terminology employed herein is for the purpose of description and not of limitation. Therefore, while the embodiments herein have been described in terms of preferred embodiments, those skilled in the art will recognize that the embodiments herein can be practiced with modification within the spirit and scope of the appended claims. 30
[0058] While embodiments of the present disclosure have been illustrated and 19 described, it will be clear that the disclosure is not limited to these embodiments only. Numerous modifications, changes, variations, substitutions, and equivalents will be apparent to those skilled in the art, without departing from the spirit and scope of the disclosure, as described in the claims. 5 ADVANTAGES OF THE INVENTION
[0059] The present invention is to provide an anthropomorphic, flexible, agile, and robust 3D bio-printing device. 10
[0060] The present invention facilitates real-time wound healing of living organisms, especially human subjects.
[0061] The present invention facilitates live monitoring of the bio-printing 15 process via proper scanning and record keeping of target area.
[0062] The present invention provides a remotely/wirelessly accessible bioprinting device. 20 [0063] The present invention provides a versatile end effector containing the above-mentioned printing device that can be mounted onto any bio-printing manipulator.
[0064] The present invention provides an effective interpretation of cuts/wounds 25 on in vivo through the involvement of artificial intelligence, thus enabling proper healing therein.
[0065] The present invention provides a bio-printing device that is portable in nature. 30 20
[0066] The present invention provides a bio-printing device comprising high resolution imaging with precision cell deposition and layering, at micrometer level of accuracy.
We Claim: 1) A bio-printing system for real-time in vivo wound healing, comprising: a) atleast one scanning unit (5) for acquiring one or more three-dimensional images of atleast one injured area; b) a user interface (4) linked to said atleast one scanning unit (5) for generating computer-aided designs based on features extracted via machine learning regression modeling of said images; c) atleast one bio-printing device (1) operable to patternly deposit bio-inks onto said injured area based on said designs; and d) a controlling unit (2) facilitating said patternly deposition by transferring plurality of instructions between said user interface (4) and said bioprinting device (1). 2) The system as claimed in claim 1, further comprising a temperature controlling unit to maintain cell viability and temperature propitious for said bio-ink deposition. 3) The system as claimed in claim 1, wherein said scanning unit (5) further comprises of atleast one position sensor for spotting said injured area, thereby assisting said scanning unit (5) to align thereon. 4) A bio-printing device for real-time in vivo wound healing, comprising: a flexible manipulator arm and an end-effector (6) contiguous to said arm for depositing bio-ink on a target area, further comprising: a) a primary mounting (14), wherein elongated end of said primary mounting (14) equips a pinion (19); b) atleast two hollow elongated secondary mountings (15a, 15b), wherein a side of said secondary mountings (15a, 15b) clamp a rack (20) to lockably engage said pinion (19), thereby allowing sliding/switching of said secondary mountings (15a, 15b) with respect to said primary mounting (14); 22 c) a scanner connected to said primary mounting (14) for real-time monitoring of said target area; d) atleast two bio-mixture filled replaceable syringes (17a, 17b) insertable inside said secondary mountings (15a, 15b) to dispense bio-inks onto said target region depending on the strength of actuation received via an inbuilt linear actuator (21); and e) atleast one ultra-violet lamp (18) attached to atleast one secondary mounting (15a, 15b) to disinfect and solidify upper layer of said bio-ink dispensed on said target area. 5) The device as claimed in claim 1, wherein said manipulator arm further comprising a base (7) affixed on a surface, a shoulder (8) attached to said base (7) via atleast one swivel joint (9), an upper arm (10) attached to said shoulder (8) via atleast a revolute joint (11), a lower arm (12) attached to said upper arm (10) via atleast another revolute joint (13) and ending with said end-effector (6). 6) The device as claimed in claim 5, wherein said manipulator is rotatable in six degrees of freedom and operational via plurality of servo motors. 7) The device as claimed in claim 1, wherein said primary mounting (14) further comprises of a servo/stepper motor actuated rotating shaft for driving said pinion (19). 8) The device as claimed in claim one, wherein bio-mixture inside said atleast two syringes (17a, 17b) consist of bio-material mixed with hydrogels of any cell type and/or a photosensitive ultra-violet curable bio-material respectively or a combination thereof. 9) The device as claimed in claim 8, wherein said bio-material is selected to be but not limited to stem cells, mesenchymal cells, coalescent cells or combination thereof. 23 10) The device as claimed in claim 1, wherein said linear actuator (21) encompasses upper portion inside each of said secondary mountings (15a, 15b) and comprises a piston (19) disposed there-below.